Single Dose of Bivalent Human Papillomavirus (HPV) Vaccine May Prevent Majority of Cervical Cancers
News
Results from a recent study published in The Lancet Oncology combined data from two large phase 3 trials and revealed that a single dose of the bivalent human papillomavirus (HPV) vaccine (Cervarix, GlaxoSmithKline) ... Read more